-
PROVIDERS
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
-
LIFE SCIENCES
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Powering Discovery: Tempus Multimodal Database
Targeting discovery is an important frontier in the fight against pancreatic cancer. Take a look at this example of how Tempus Multimodal Database enabled a pharmaceutical company to more quickly identify pancreatic cancer subtypes’ molecular signatures.
-
10/17/2024Precision pathways: Insights & strategies to navigate regulatory requirements for oncology diagnostics
Watch as we explore the evolving regulatory landscape of diagnostics in oncology. Gain insights into new regulatory requirements, submission pathways, and emerging trends. Learn from industry experts about strategic approaches to FDA requirements to help inform your diagnostic development and precision medicine pipelines.
Watch replay -
10/11/2024Revolutionizing drug screening with Tempus AI’s advanced imaging capabilities
Learn how Tempus AI's noninvasive imaging techniques allow for the continuous study of the same organoids across various assays, preserving their viability for longitudinal analysis and multiplexed testing.
Read more -
10/01/2024Shaping drug development with tumor organoids and RWD
Explore how Tempus addresses drug development challenges through its extensive 3D patient-derived organoid (PDO) biorepository and real-world data (RWD) platform.
Watch replay